AU2013241713A1 - Easily purifiable synthon composition - Google Patents

Easily purifiable synthon composition Download PDF

Info

Publication number
AU2013241713A1
AU2013241713A1 AU2013241713A AU2013241713A AU2013241713A1 AU 2013241713 A1 AU2013241713 A1 AU 2013241713A1 AU 2013241713 A AU2013241713 A AU 2013241713A AU 2013241713 A AU2013241713 A AU 2013241713A AU 2013241713 A1 AU2013241713 A1 AU 2013241713A1
Authority
AU
Australia
Prior art keywords
formula
composition
compound
cassette
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013241713A
Other languages
English (en)
Inventor
Rajiv Bhalla
Alexander Jackson
Gareth Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of AU2013241713A1 publication Critical patent/AU2013241713A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2013241713A 2012-03-30 2013-03-28 Easily purifiable synthon composition Abandoned AU2013241713A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261617698P 2012-03-30 2012-03-30
GBGB1205703.0A GB201205703D0 (en) 2012-03-30 2012-03-30 Synthon composition
GB1205703.0 2012-03-30
US61/617,698 2012-03-30
PCT/EP2013/056720 WO2013144301A2 (en) 2012-03-30 2013-03-28 Synthon composition

Publications (1)

Publication Number Publication Date
AU2013241713A1 true AU2013241713A1 (en) 2014-10-02

Family

ID=46160043

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013241713A Abandoned AU2013241713A1 (en) 2012-03-30 2013-03-28 Easily purifiable synthon composition

Country Status (10)

Country Link
US (1) US20160022845A1 (https=)
EP (1) EP2830667A2 (https=)
JP (1) JP2015511620A (https=)
KR (1) KR20140141604A (https=)
CN (1) CN104168924A (https=)
AU (1) AU2013241713A1 (https=)
CA (1) CA2866226A1 (https=)
GB (1) GB201205703D0 (https=)
IN (1) IN2014DN06805A (https=)
WO (1) WO2013144301A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161478A (en) 1974-05-02 1979-07-17 General Electric Company Photoinitiators
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
US8257680B1 (en) * 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
EP2110367A1 (en) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Purification strategy for direct nucleophilic procedures
WO2010066380A1 (en) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
WO2011141515A1 (en) * 2010-05-14 2011-11-17 Bayer Pharma Aktiengesellschaft Diagnostic agents for amyloid beta imaging

Also Published As

Publication number Publication date
WO2013144301A3 (en) 2013-11-21
EP2830667A2 (en) 2015-02-04
IN2014DN06805A (https=) 2015-06-26
CA2866226A1 (en) 2013-10-03
WO2013144301A2 (en) 2013-10-03
KR20140141604A (ko) 2014-12-10
CN104168924A (zh) 2014-11-26
GB201205703D0 (en) 2012-05-16
US20160022845A1 (en) 2016-01-28
JP2015511620A (ja) 2015-04-20

Similar Documents

Publication Publication Date Title
KR102137348B1 (ko) 시트레이트 완충제 내 18ｆ―플루시클로빈 조성물
JP6997519B2 (ja) 新規製剤及び合成方法
CA2851595C (en) Method for the synthesis of 18f-labelled biomolecules
EP3774698B1 (en) Solid phase extraction
JP6446268B2 (ja) クエン酸緩衝液中の１８ｆ−フルシクロビン組成物
US20160022845A1 (en) Synthon composition
EP2590683B1 (en) Method for production of f-18 labeled amyloid beta ligands
AU2014242897B2 (en) Radiolabelling process
WO2012084928A1 (en) Radioiodinated guanidines
GB2561122B (en) Composition comprising [18F]-Fluciclovine
BR112015024344B1 (pt) Método para obter uma composição
NZ624250B2 (en) 18f-fluciclovine compositions in citrate buffers

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period